OBJECTIVES: To assess the efficacy of the administration of magnesium as a method for the prevention of postoperative atrial fibrillation (AF) and to evaluate its influence on hospital length of stay (LOS) and mortality. METHODS: Literature search and meta-analysis of the randomised control studies published since 1966. RESULTS: 20 randomised trials were identified, enrolling a total of 2490 patients. Study sample size varied between 20 and 400 patients. Magnesium administration decreased the proportion of patients developing postoperative AF from 28% in the control group to 18% in the treatment group (odds ratio 0.54, 95% confidence interval (CI) 0.38 to 0.75). Data on LOS were available from seven trials (1227 patients). Magnesium did not significantly affect LOS (weighted mean difference -0.07 days of stay, 95% CI -0.66 to 0.53). The overall mortality was low (0.7%) and was not affected by magnesium administration (odds ratio 1.22, 95% CI 0.39 to 3.77). CONCLUSION: Magnesium administration is an effective prophylactic measure for the prevention of postoperative AF. It does not significantly alter LOS or in-hospital mortality.
OBJECTIVES: To assess the efficacy of the administration of magnesium as a method for the prevention of postoperative atrial fibrillation (AF) and to evaluate its influence on hospital length of stay (LOS) and mortality. METHODS: Literature search and meta-analysis of the randomised control studies published since 1966. RESULTS: 20 randomised trials were identified, enrolling a total of 2490 patients. Study sample size varied between 20 and 400 patients. Magnesium administration decreased the proportion of patients developing postoperative AF from 28% in the control group to 18% in the treatment group (odds ratio 0.54, 95% confidence interval (CI) 0.38 to 0.75). Data on LOS were available from seven trials (1227 patients). Magnesium did not significantly affect LOS (weighted mean difference -0.07 days of stay, 95% CI -0.66 to 0.53). The overall mortality was low (0.7%) and was not affected by magnesium administration (odds ratio 1.22, 95% CI 0.39 to 3.77). CONCLUSION:Magnesium administration is an effective prophylactic measure for the prevention of postoperative AF. It does not significantly alter LOS or in-hospital mortality.
Authors: S F Aranki; D P Shaw; D H Adams; R J Rizzo; G S Couper; M VanderVliet; J J Collins; L H Cohn; H R Burstin Journal: Circulation Date: 1996-08-01 Impact factor: 29.690
Authors: J O Wistbacka; J Koistinen; K E Karlqvist; M V Lepojärvi; R Hanhela; J Laurila; J Nissinen; R Pokela; E Salmela; A Ruokonen Journal: J Cardiothorac Vasc Anesth Date: 1995-04 Impact factor: 2.628
Authors: Mei Chung; Ethan M Balk; Stanley Ip; Gowri Raman; Winifred W Yu; Thomas A Trikalinos; Alice H Lichtenstein; Elizabeth A Yetley; Joseph Lau Journal: Am J Clin Nutr Date: 2009-02-25 Impact factor: 7.045
Authors: Jeffrey R Misialek; Faye L Lopez; Pamela L Lutsey; Rachel R Huxley; James M Peacock; Lin Y Chen; Elsayed Z Soliman; Sunil K Agarwal; Alvaro Alonso Journal: Circ J Date: 2012-10-06 Impact factor: 2.993
Authors: Pamela L Lutsey; Alvaro Alonso; Erin D Michos; Laura R Loehr; Brad C Astor; Josef Coresh; Aaron R Folsom Journal: Am J Clin Nutr Date: 2014-07-16 Impact factor: 7.045